ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
0.5375
0.00
(0.00%)
Cerrado 03 Diciembre 10:30AM

Su centro para precios en tiempo real, ideas y debates en vivo

Estadísticas y detalles clave

Último Precio
0.5375
Postura de Compra
0.50
Postura de Venta
0.575
Volume Operado de la Acción
31,111
0.5375 Rango del Día 0.5375
0.525 Rango de 52 semanas 35.00
Capitalización de Mercado [m]
Precio Anterior
0.5375
Precio de Apertura
0.5375
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
530,427
Acciones en circulación
427,346,895
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-0.74
Beneficio por acción (BPA)
-0.01
turnover
396k
Beneficio neto
-3.14M

Acerca de Theracryf Plc

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
Sede
Cheshire, Gbr
Fundado
-
Theracryf Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker TCF. The last closing price for Theracryf was 0.54p. Over the last year, Theracryf shares have traded in a share price range of 0.525p to 35.00p.

Theracryf currently has 427,346,895 shares in issue. The market capitalisation of Theracryf is £2.30 million. Theracryf has a price to earnings ratio (PE ratio) of -0.74.

TCF Últimas noticias

TheraCryf narrows loss, advances drug programmes after acquisition

TheraCryf PLC said on Thusday its half-year pretax loss narrowed as it advanced drug development programmes in oncolo ...

Theracryf PLC Half-year Report

Theracryf PLC 28 November 2024   TheraCryf plc   ("TheraCryf" or "the Company" or "the Group")   Half Year Report to 30 September 2024      Alderley Park, UK 28 November 2024. TheraCryf plc...

TheraCryf gets European patent for drug acquired from new subsidiary

TheraCryf PLC on Wednesday confirmed it had been awarded a Composition of Matter patent in Europe for a new drug trea ...

Theracryf PLC Holding(s) in Company

Theracryf PLC 15 November 2024   TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BSVYN304 Issuer Name THERACRYF PLC UK or Non-UK Issuer UK 2. Reason for...

Theracryf PLC Issue of Equity and Total Voting Rights

Theracryf PLC 14 November 2024     TheraCryf plc ("TheraCryf", the "Company" or the "Group") Issue of Equity and Total Voting Rights Alderley Park, UK - 14 Nov 2024: TheraCryf plc (AIM:...

Theracryf PLC Notice of Results

Theracryf PLC 14 November 2024   TheraCryf plc ("TheraCryf", the "Company" or the "Group")   Notice of Interim results and Presentation via Investor Meet Company   Alderley Park, 14 November...

EXECUTIVE CHANGES: Sanderson hires in UK and US; Oberon gets Penny

The following is a round-up of London-listed company director and manager changes announced on Friday and Monday and ...

Theracryf PLC Passing of Dr Sue Foden, Chair

Theracryf PLC 04 November 2024     TheraCryf plc ("TheraCryf", the "Company" or the "Group") Passing of  Dr Sue Foden, Chair Alderley Park, UK - 4 November 2024: TheraCryf plc (AIM: TCF), the...

Theracryf PLC Grant of Options and PDMR Dealings

Theracryf PLC 29 August 2024     TheraCryf plc ("TheraCryf", the "Company" or the "Group") Grant of Options, Surrender of Existing Options and PDMR Dealings Alderley Park, UK - 29 August 2024:...

Theracryf PLC Holding(s) in Company

Theracryf PLC 08 August 2024   TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BSVYN304 Issuer Name THERACRYF PLC UK or Non-UK Issuer UK 2. Reason for...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1000.53750.550.53752768450.5429662DE
4-0.0625-10.41666666670.60.60.5256056340.54027066DE
12-0.1625-23.21428571430.70.7750.5255304270.6429771DE
26-0.1625-23.21428571430.710.5258581200.79311735DE
52-34.4625-98.464285714335350.5254875680.78830288DE
156-34.4625-98.464285714335350.5251633800.78830288DE
260-34.4625-98.464285714335350.525978990.78830288DE

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
SCGLSealand Capital Galaxy Limited
0.54p
(80.00%)
33.76M
OBDOxford Biodynamics Plc
2.11p
(55.15%)
8.3M
MIRIMirriad Advertising Plc
0.18p
(33.33%)
23.04M
CLCOCloudcoco Group Plc
0.26p
(30.00%)
3.42M
IESInvinity Energy Systems Plc
15.00p
(27.66%)
4.57M
ZNTZentra Group Plc
3.50p
(-36.36%)
221.85k
UOGUnited Oil & Gas Plc
0.125p
(-34.21%)
123.45M
SYSSysgroup Plc
21.50p
(-24.56%)
788.98k
ADAAdams Plc
3.50p
(-22.22%)
25k
DSMDowning Strategic Micro-cap Investment Trust Plc
3.70p
(-21.28%)
22.32k
ORCPOracle Power Plc
0.0525p
(-7.89%)
3.63B
NTVONativo Resources Plc
0.0023p
(-8.00%)
1.51B
SYMESupply@me Capital Plc
0.0031p
(-10.14%)
1.11B
KEFIKefi Gold And Copper Plc
0.524p
(-19.63%)
567.23M
ENETEthernity Networks Ltd
0.1425p
(18.75%)
551.92M
Budots Budots 1 minuto hace
The Future of $CBDW 1606 Corporation: Expansion into New Sectors https://cbdw.ai/the-ai-chatbot-market-in-2025-growth-prospects-and-the-strategic-expansion-of-1606-corporation-cbdw/
CBDW
Catpole Catpole 1 minuto hace
Latest development sounds interesting. I like the potential revenue and spin off possibilities. I suspect some share accumulation will begin as PSRU continues with this new project.
PSRU
Sharp Shooter Sharp Shooter 2 minutos hace
Based on your analysis historically share price tends to return to it's pre-split price whether or not it is a reverse or forward split .. No ?
BDPTD
Doubledown75 Doubledown75 2 minutos hace
Kind of like that Uganda story. Showed people walking around with bowling ball sized nuggets lol.
Mining asteroids.....all kinds of BS propaganda out there;)
NBRI
StockRocket StockRocket 2 minutos hace
What does this mean?
NXMH
Budots Budots 2 minutos hace
$CBDL proudly announces the launch of its groundbreaking Delta-8 100mg Gummies, specially formulated to support individuals living with Alzheimer's disease. https://finance.yahoo.com/news/cbd-life-sciences-inc-cbdl-130000954.html
CBDL
Budots Budots 2 minutos hace
$CBDL proudly announces the launch of its groundbreaking Delta-8 100mg Gummies, specially formulated to support individuals living with Alzheimer's disease. https://finance.yahoo.com/news/cbd-life-sciences-inc-cbdl-130000954.html
CBDL
weedtrader420 weedtrader420 2 minutos hace
Crypto is getting a big Christmas present this year $120,000 BITCOIN by Christmas
BTCUSD
manibiotech manibiotech 2 minutos hace
Exactly
Execution is as important if not more important than science . 
NWBO
Kaiserwave Kaiserwave 2 minutos hace
I'll take some delicious 9s.
RDAR
7longyears 7longyears 2 minutos hace
Damn forgot to ask him what year. 2024 or 2025. PROBABLY want matter.
DROP
MJAM2020 MJAM2020 2 minutos hace
Can't wait to hear more on the snippet below. I'm looking for further details on all of the acquisitions soon and exactly where we fit in etc. Explained to us like we are 5 so myself and a good % of the retail market can comprehend where we stand and then updates on other initiatives within the bus
FOXO
dinogreeves dinogreeves 3 minutos hace
Buy VCNX too, going to 20...30....40 dollars.
VCNX
GREGG THE GREEK GREGG THE GREEK 3 minutos hace
What is even stranger is not selling when one had the chance to do so profitably. Especially someone who has been in XCRT for 17 or 27 yrs or whatever the made up story is. Then continue to rejoice when the SP drops. Talk about strange. Things which make you go Ghandi !!!


XCRT
qualityincolor qualityincolor 3 minutos hace
$44 mill is nothing here. 
RDAR
qwertytrader qwertytrader 3 minutos hace
Chinese markets continue to shot themselves in the foot in a pre-emptive battle with Trump.

Warning Shot: China Bans Exports Of Gallium, Germanium To US As Tit-For-Tat Chip War Escalates

The Chinese market value with continue to sink. Their allies do not have the resour
YANG
fza fza 3 minutos hace
Sorry for the slip up, I wasn't aware of clicking on a button. I remain cautiously optimistic.
KBLB
manibiotech manibiotech 3 minutos hace
So you are saying that defendants are not given an opportunity to respond to the notice ?
NWBO
declaes declaes 3 minutos hace
💤
GRST
learningcurve2020 learningcurve2020 3 minutos hace
50-100 is just a fraction of 1% of retail investors burned by this management.  
NWBO
badog badog 3 minutos hace
Hey...pops is just frustrated that he is STUCK. Nothing else he can do with his 250 shares.

Badog
ERHE
Mr Smith 34 Mr Smith 34 4 minutos hace
Don't forget this gem from the audit as well.
Note 6. Related Party Transactions
As of December 31, 2023 and 2022, the Company owed the previous CEO $66,194 and $37,262, respectively, for compensation not yet paid.
SPZI

Su Consulta Reciente

Delayed Upgrade Clock